Insider trading

Period: 120 months Stock: PCRX Plan: Discretionary × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

34 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

34 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

34 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

34 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
34 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
34 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

34 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
17 Mar 2026
Froimson Mark Director
Sold at will
$10.91K 500 at 21.81
2.4%
Not planned
7 Aug 2025
BIGAL MARCELO Director
Sold at will
$116.27K 4,912 at 23.67
30.1%
Not planned
4 Jun 2025
WILLIAMS KRISTEN Chief Administrative Officer
Sold at will
$377.23K 14,376 at 26.24
8.2%
Not planned
4 Jun 2025
RIKER LAUREN Senior Vice President, Finance
Sold at will
$146.21K 5,578 at 26.21
8.6%
Not planned
16 Aug 2024
BIGAL MARCELO Director
Bought
$20.03K 1,512 at 13.25
17.5%
16 Aug 2024
Brege Laura Director
Bought
$12.81K 1,000 at 12.81
6.0%
First buy on file
14 Aug 2024
YANG MICHAEL J. Director
Bought
$25.80K 2,000 at 12.90
38.2%
First buy on file
12 Aug 2024
Lee Frank D. Chief Executive Officer
Bought
$99.99K 8,264 at 12.10
8.3%
First buy on file
12 Aug 2024
BIGAL MARCELO Director
Bought
$40.83K 3,400 at 12.01
65.0%
First buy on file
12 Aug 2024
Froimson Mark Director
Bought
$16.21K 1,400 at 11.58
10.7%
First buy on file
8 Mar 2024
PACE GARY W Director
Sold at will
$2.75M 90,000 at 30.60
80.3%
Sold half or more
7 Mar 2024
PACE GARY W Director
Sold at will
$870.60K 28,257 at 30.81
20.1%
Not planned
6 Mar 2024
PACE GARY W Director
Sold at will
$31.63K 1,066 at 29.67
0.8%
Not planned
2 Aug 2023
WINSTON ROY Chief Medical Officer
Sold at will
$17.75K 509 at 34.88
1.0%
Not planned
7 Jun 2023
STACK DAVID M CEO and Chairman
Sold at will
$201.67K 5,326 at 37.87
3.3%
Not planned
7 Jun 2023
WINSTON ROY Chief Medical Officer
Sold at will
$70.32K 1,857 at 37.87
4.3%
Not planned
7 Jun 2023
Reinhart Charles A. III Chief Financial Officer
Sold at will
$51.91K 1,371 at 37.87
3.9%
Not planned
7 Jun 2023
WILLIAMS KRISTEN Chief Administrative Officer
Sold at will
$51.38K 1,357 at 37.87
6.1%
Not planned
7 Jun 2023
Ellis Ronald J. Jr. Chief Strategy Officer
Sold at will
$44.00K 1,162 at 37.87
3.6%
Not planned
7 Jun 2023
REINHARDT MAX President, Rest of World
Sold at will
$41.61K 1,099 at 37.87
3.6%
Not planned
7 Jun 2023
McLoughlin Dennis Chief Customer Officer
Sold at will
$40.02K 1,057 at 37.87
2.7%
Not planned
7 Jun 2023
RIKER LAUREN Senior Vice President, Finance
Sold at will
$23.32K 616 at 37.87
3.1%
Not planned
7 Jun 2023
SLONIN JONATHAN Chief Clinical Officer
Sold at will
$18.55K 490 at 37.87
1.3%
Not planned
6 Jun 2023
STACK DAVID M CEO and Chairman
Sold at will
$197.22K 5,058 at 38.99
3.1%
Not planned
6 Jun 2023
WINSTON ROY Chief Medical Officer
Sold at will
$69.36K 1,779 at 38.99
4.0%
Not planned
6 Jun 2023
WILLIAMS KRISTEN Chief Administrative Officer
Sold at will
$50.73K 1,301 at 38.99
5.5%
Not planned
6 Jun 2023
Reinhart Charles A. III Chief Financial Officer
Sold at will
$48.19K 1,236 at 38.99
3.4%
Not planned
6 Jun 2023
Ellis Ronald J. Jr. Chief Strategy Officer
Sold at will
$43.44K 1,114 at 38.99
3.4%
Not planned
6 Jun 2023
REINHARDT MAX President, Rest of World
Sold at will
$41.10K 1,054 at 38.99
3.4%
Not planned
6 Jun 2023
McLoughlin Dennis Chief Customer Officer
Sold at will
$39.54K 1,014 at 38.99
2.5%
Not planned
6 Jun 2023
RIKER LAUREN Senior Vice President, Finance
Sold at will
$23.04K 591 at 38.99
2.9%
Not planned
6 Jun 2023
SLONIN JONATHAN Chief Clinical Officer
Sold at will
$18.36K 471 at 38.99
1.3%
Not planned
5 Jun 2023
HASTINGS PAUL J Director
Sold at will
$22.24K 580 at 38.34
8.1%
Not planned
11 May 2023
PACE GARY W Director
Sold at will
$209.53K 5,015 at 41.78
3.5%
Not planned
Showing 1–34 of 34.